Search clinical trials for: cancer in lymph nodes

Total 465742 results

University of Alexandria

Completed

The Usefulness of Staining Lymph Nodes During Operations for Cancer Thyroid in Detecting the Nodes That Have Cancer

Thyroid Cancer | Lymph Node Metastasis

Egypt
University Hospital, Strasbourg, France

Unknown

Sentinel Node in Colon Cancer

Colon Cancer

France
University Hospital, Strasbourg, France

Completed

Identification of Sentinel Lymph Nodes With Methylene Blue and Isotope

Infiltrative Breast Cancer

France
Tel-Aviv Sourasky Medical Center

Unknown

Correlation Between Fluorodeoxyglucose (FDG) and FLT Uptake and Gene-Expression Oncotype Assay in Patients With Breast Cancer

Breast Cancer

Israel
Radboud University Medical Center
ZonMw: The Netherlands Organisation for Health Research and Development

Unknown

MR-Lymphography and Lymph Node Staging in Prostate Cancer

Prostatic Neoplasms | Lymphatic Metastasis

Netherlands
Kartos Therapeutics, Inc.

Recruiting

Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib (POIESIS)

Primary Myelofibrosis | Myelofibrosis | Post-PV MF | Post-ET Myelofibrosis | MF

United States
Wake Forest University Health Sciences
Brookdale University Hospital Medical Center; Atrium Health Levine Cancer Institute

Not yet recruiting

Evaluation of the Pathobiology of CALR-mutated MPN Cells

Myeloproliferative Neoplasm

United States
Shanghai Ming Ju Biotechnology Co., Ltd.

Not yet recruiting

CD19-targeted CAR T Cells for Relapsed or Refractory (R/R) Large B-cell Lymphoma

Non-Hodgkin Lymphoma | Large B-cell Lymphoma

China
The First Affiliated Hospital of Xiamen University
Fujian Cancer Hospital; Chinese PLA General Hospital; Jiangxi Provincial Cancer... and other collaborators

Recruiting

Prospective Clinical Study of Obrutinib in Combination With Rituximab (OR) for Primary Marginal Zone Lymphoma (MZL) That Failed or Not Suitable for Local Therapy

Marginal Zone Lymphoma

China
Henan Cancer Hospital

Recruiting

L218CAR19 in Patients With Relapsed/Refractory B-cell Lymphoma

Relapsed/Refractory B-cell Lymphomas

China
Queensland Centre for Gynaecological Cancer
Royal Brisbane and Women's Hospital

Not yet recruiting

Australian National Vulvar Cancer Trial (ANVU)

Ultrasound Therapy; Complications | Lymph Node Metastasis | Groin Node | Vulvar Cancer Stage II | Vulvar Cancer Stage I

Australia
The Netherlands Cancer Institute
Maarten van de Weijden Foundation; AVL Foundation

Not yet recruiting

OPTImaL:Optimisation of Treatment for Patients With Low Stage Triple-negative Breast Cancer With High Stromal Tumor-infiltrating Lymphocytes (OPTImaL)

Breast Cancer Stage I | Triple Negative Breast Cancer (TNBC)

Netherlands
M.D. Anderson Cancer Center

Not yet recruiting

A Phase I Study Investigating the Combination of Cladribine, Low Dose Cytarabine and Sorafenib Alternating With Decitabine in Pediatric Relapsed and Refractory Acute Leukemias

Refractory Acute Leukemia | Relapsed Acute Leukemia

United States
Dana-Farber Cancer Institute
Merck Sharp & Dohme LLC

Not yet recruiting

Pembrolizumab + Chemotherapy in Newly Diagnosed PCNSL

Lymphoma | Primary Central Nervous System Lymphoma

United States
Shanghai Juncell Therapeutics

Not yet recruiting

A Phase Ⅰb Study on Autologous GC101 TIL Injection for the Treatment of NSCLC (MIZAR-005)

Non Small Cell Lung Cancer | Non Small Cell Lung Cancer Metastatic
Tianjin Medical University Cancer Institute and...

Not yet recruiting

Zanubrutinib and G-CHOP in Untreated Intermediate-high Risk Follicular Lymphoma

FL
The First Affiliated Hospital with Nanjing Medical...
Nanjing Legend Biotech Co.

Not yet recruiting

LCAR-M61S and LCAR-M61D in Treatment of Relapsed/Refractory Multiple Myeloma

Relapsed/Refractory Multiple Myeloma

China
Janssen-Cilag Ltd.

Recruiting

A Real-world Study in Participants With Smoldering Multiple Myeloma

Smoldering Multiple Myeloma

France
San Luigi Gonzaga Hospital
Azienda Ospedaliera Città della Salute e della Scienza di Torino; Fondazione... and other collaborators

Recruiting

Upfront Surgery Versus NeoAdjuvant Chemotherapy Followed by Surgery for Resectable Advanced Gastric Cancer: SNAC Study (SNAC)

Gastric Cancer

Italy
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Virus-associated Tumour Microenvironment (VIRONMENT)

Lymphoma | Cancers of the Lung | Cancer Anal Canal
Navy General Hospital, Beijing

Not yet recruiting

VA Conditioning Regimen Allo-HSCT for Elderly Higher-risk MDS

Higher-risk Myelodysplastic Syndromes

China
Yuanquan Yang

Not yet recruiting

Siltuximab for the Prevention of Severe Immune-Related Adverse Events During Immune Checkpoint Inhibitor Rechallenge in Patients With Advanced Cancer, CIRES Trial

Advanced Malignant Solid Neoplasm | Hematopoietic and Lymphatic System Neoplasm

United States
Massachusetts General Hospital
National Institutes of Health (NIH)

Not yet recruiting

BMT-CARE: Psychosocial Intervention for Transplant Caregivers (BMT-CARE)

Hematologic Malignancy | Bone Marrow Transplant Complications

United States
Scientific Institute San Raffaele

Recruiting

The Lymphocytic Infiltrate of Lung Tumors. (TREGILC)

Lung Cancer | Immune System

Italy
Massachusetts General Hospital
National Institutes of Health (NIH)

Not yet recruiting

Novel Digital Application for Patients With Acute Leukemia (NAVIGATE)

Relapsed Adult Acute Myeloid Leukemia | High Risk Acute Myeloid Leukemia | Primary Refractory Acute Myeloid Leukemia

United States
Second Affiliated Hospital of Xi'an Jiaotong University

Recruiting

Improvements in Thyroid Tumor Surgery and the Prognosis, Diagnosis, Recurrence and Metastasis of Patients

Carcinogenesis | Papillary Thyroid Cancer | Lymph Node Metastasis

China
Xianmin Song, MD

Recruiting

Reduced Intensity Conditioning With Thiotepa Combined With Bu/Flu/Ara-C in Allo-HSCT for Relapsed or Refractory Peripheral T-cell Lymphoma.

Peripheral T Cell Lymphoma

China
Dana-Farber Cancer Institute
National Cancer Institute (NCI); American Society of Clinical Oncology

Not yet recruiting

Driving Inclusivity, Validity, and Equity in Research Through Strategic Engagement (DIVERSE) (DIVERSE)

Leukemia | Blood Cancer

United States
Kerry Rogers

Not yet recruiting

Pirtobrutinib (LOXO-305) and Venetoclax for the Treatment of Patients With CLL or SLL Resistant to Covalent BTKi

Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma

United States
Institut de Recherches Internationales Servier
Servier Bio-Innovation LLC

Not yet recruiting

Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation (PyramIDH)

Myelodysplastic Syndromes (MDS) | Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS)
Azienda Ospedaliero-Universitaria di Parma

Recruiting

Evaluation of Intra-operative Photographs for the Assessment of a Proper Lymphadenectomy in Minimally-invasive Gastrectomies for Gastric Cancer (PhotoNodes) (PhotoNodes)

Laparoscopic Surgery | Gastric Cancer | Gastric Adenocarcinoma | Robotic Surgery | Survival Outcomes | Quality Of Care | Gastrectomy for Gastric Cancer | Lymphadenectomy | Minimally Invasive Surgery | Survival Analysis

Italy
M.D. Anderson Cancer Center

Not yet recruiting

A Phase I Study of Hyper-CVAD In Combination With Venetoclax In Pediatric Patients With Relapsed or Refractory Acute Leukemias That Are of the Lymphoid Lineage Including Bi-Phenotypic or Undifferentiated Leukemias

Refractory Acute Leukemia | Undifferentiated Leukemia | Relapsed Acute Leukemia | Bi-Phenotypic Leukemia

United States
Minovia Therapeutics Ltd.

Recruiting

A Study to Evaluate the MNV-201 in Patients With Low Risk MDS

Myelodysplastic Syndromes

Israel
Nanjing IASO Biotechnology Co., Ltd.

Recruiting

A Phase III Study of Eque-cel in Subjects With Len-refractory RRMM (FUMANBA-03) (FUMANBA-03)

Multiple Myeloma

China
National Cancer Institute (NCI)

Not yet recruiting

Testing Teclistamab (TECVAYLI) in Combination With Iberdomide for Hard-to-Treat Multiple Myeloma

Multiple Myeloma
Tr1X, Inc.

Recruiting

Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)

Myelodysplastic Syndromes | Hematologic Malignancy | Hematopoietic Stem Cell Transplant | Acute Myeloid Leukemia in Remission | GVHD, Chronic | GVHD,Acute | GvHD | Acute Lymphoblastic Leukemia, Adult B-Cell | Cancer Remission | Acute Lymphoblastic Leukemia, Adult T-Cell | Chronic Myelomonocytic Leukemia,...

United States
TC Biopharm

Not yet recruiting

ACHIEVE2 - Safety and Preliminary Efficacy of Intravenous TCB008 in Patients With Relapse or Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)/AML (ACHIEVE2)

Acute Myeloid Leukemia | Myelodysplastic Syndromes
Stanford University
Janssen, LP

Not yet recruiting

Talquetamab & Lenalidomide as Post Stem Cell Transplant Maintenance in Multiple Myeloma

Multiple Myeloma | Post Stem Cell Transplant

United States
Koo Foundation Sun Yat-Sen Cancer Center

Recruiting

Ga-68-CXCR4 PET/CT in Indolent B-cell Lymphoma (PentixaFor)

Indolent B-Cell Non-Hodgkin Lymphoma

Taiwan
Qilu Pharmaceutical Co., Ltd.

Not yet recruiting

QL0911 for the Treatment of Cancer Treatment-Induced Thrombocytopenia

Cancer Treatment-Induced Thrombocytopenia
Stemline Therapeutics, Inc.

Not yet recruiting

A Study of Tagraxofusp in Combination With Venetoclax and Azacitidine in Adults With Untreated CD123+ Acute Myeloid Leukemia Who Cannot Undergo Intensive Chemotherapy

Acute Myeloid Leukemia

United States
Abramson Cancer Center at Penn Medicine
Genmab

Not yet recruiting

Epcoritamab-CAR T Cells for Large B-cell Lymphomas

Lymphoma, Non-Hodgkin | High-grade B-cell Lymphoma | Refractory Diffuse Large B-cell Lymphoma | Relapsed Diffuse Large B Cell Lymphoma | Transformed Indolent Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma

United States
University Hospital, Clermont-Ferrand

Not yet recruiting

Effect of APA on Sleep Quality in Children With Cancer From 5 to 16 Years (APANYX)

Sleep | Child, Only | Blood Cancer | Adapted Physical Activity

France
Ningbo No. 1 Hospital

Recruiting

First-line Treatment of PCNSL With the Combination of Orelabrutinib, Rituximab, and Methotrexate (ORM Regimen)

Primary Central Nervous System Lymphoma

China
City of Hope Medical Center
National Cancer Institute (NCI)

Not yet recruiting

Regorafenib in Combination With Venetoclax and Azacitidine for the Treatment of Patients With Relapsed or Refractory Acute Myeloid Leukemia

Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Myelodysplastic Syndrome | Myelodysplastic Syndrome/Acute Myeloid Leukemia

United States
University Hospital, Basel, Switzerland

Not yet recruiting

TIL Therapy in Non-small-cell Lung Cancer (NSCLC) Patients (BaseTIL-02)

Non-Small Cell Lung Cancer

Switzerland
City of Hope Medical Center
National Cancer Institute (NCI)

Not yet recruiting

Mosunetuzumab and Polatuzumab Vedotin for the Treatment of Patients With Relapsed or Refractory Grade 1-3a Follicular Lymphoma

Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3a Follicular Lymphoma | Refractory Grade 1 Follicular Lymphoma | Refractory Grade 2 Follicular Lymphoma | Refractory Grade 3a Follicular Lymphoma

United States
Guangdong Provincial People's Hospital

Not yet recruiting

Randomized Study of ABC-14 Regimen Compared With "3+7" Standard Induction Therapy or AB-14 for ND AML

Acute Myeloid Leukemia

China
Zumutor Biologics Inc.

Recruiting

Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors

Colorectal Cancer | Esophageal Cancer | Prostate Cancer | Non Small Cell Lung Cancer | Triple Negative Breast Cancer | Pancreas Adenocarcinoma | Diffuse Large B Cell Lymphoma | Head and Neck Squamous Cell Carcinoma | Urothelial Carcinoma | Biliary Tract Cancer | High Grade Ovarian Serous Adenocarcinoma

United States
Georgetown University
Regeneron Pharmaceuticals

Not yet recruiting

Neoadjuvant Chemo-Immunotherapy and Surgical Resection in Locally Advanced Non-small Cell Lung Cancer With N3 Lymph Node Involvement (NEO-SURG)

Non-small Cell Lung Cancer Stage III

United States

Search clinical trials for: cancer in lymph nodes

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations